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2012, according the infection control guideline in our hospital, an active
surveillance program for CRAB was initiated for all patients admitted to
the SICU and MICU and had just transferred from intensive care units
and respiratory care units of other healthcare institutes . 4% chlorhexidine
for bed-bath and strict contact isolation were routinely applied for these
patients until negative bacterial sputum cultures. A unit-based infection
control nurse had regularly checkup with real-time feedback about the
compliance of CRAB infection control policy , A committee convened to
track nosocomial CRAB infection data and prevent nosocomial infections.
Results: During the intervention period, the antibiotic susceptivility of CRAB
nosocomial infection in ICUs were 61.5% in 2012, 27% in 2013 and 13% in first
half of 2014. The pre-intervention antibiotic susceptivility of CRAB nosoco-
mial infection was 65% in 2010-2011. The pre-intervention antibiotic suscep-
tivility of CRAB nosocomial infection was significantly higher since active
CRAB control programs.The Chi-square test: p value is 0.030.
Figure. 2010 first half of 2014 Taipei Medical University Hospital、Medi-
cal center、Regional hospitals、Taipei ICU CRAB surveillance (TNIS).
Figure. 2011 4Q- 2014 3Q Taipei Medical University Hospital ICU CRAB
clinical isolated and healthcare-associated infection(HAI) surveillance.
Conclusions: Target active surveillance and decolonization programs for
CRAB in the adult ICUs setting can effectively reduce the incidence of
CRAB infections.
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IMPACTS OF VENTILATOR-ASSOCIATED PNEUMONIA IN RAJAVITHI
HOSPITAL VAP AT TERTIARY CARE IN THAILAND
Siriporn Sangsawang, R.N., ICN, Pranom Daungjai, R.N.. Rajavithi Hospital,
Bangkok, Thailand
Purpose: Ventilator-associated pneumonia (VAP) causes morbidity and mor-
tality in critical patients. Studies report incidence of pneumonia in a hospital
that does not occur in patients on mechanical ventilation (MV) 0.5-2.0 per
cent of infections in hospitals, but the incidence is as high as 20-fold in-
crease in patients on a ventilator. Impacts of VAP are associated with
increased health care costs and durations of MV. This study aims to deter-
mine the impacts of VAP in Rajavithi Hospital.
Methods: This was a prospective study in all patients receiving MV and expe-
rienced VAP in 22 medical wards. Data were collected between October 2010
and January 2011. Mortality rate, duration of MV, and cost of patient care
from VAP were investigated. The Ethics committee, Rajavithi hospital
approved this study.
Results: One hundred and seven cases of VAP (13.7%) were identified in
779 patients receiving MV. The incidence of VAP 11.3/1,000 ventilator
days was observed. Most VAP cases were male (15.7%) and 11.8% were fe-
male. Patients aged 60 years or older were found 24.4 percent. VAP
occurred most often in cardiovascular system (35.5%) followed by respira-
tory system (25.2%), and brain and nervous system (14%). VAP wasoccurred in 50% of respiratory and nasal intubation cases and 13.6% from
oral intubation cases from pneumonia. The number of airway repeatedly
found to be correlated with infection while 14.4% without respirators
were also infected. The number of 1-8 antibiotic treatments was used in
VAP cases. Forty-eight patients on a ventilator died. The number of deaths
from VAP was 12 cases.
Conclusions: The incidence of VAP was most found in elderly people who
will be the majority of the population in the future. Diseases and treatment
in older people seems likely to be more complicated. Health officers should
cooperate in planning and following guidelines to prevent infection from
VAP.PS 2-515
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Purpose: The Japanese Society for Infection Prevention and Control
launched the device-associated infection surveillance project in neonatal
intensive care units (NICUs). The purpose of this study was to evaluate the
results and to explain our surveillance system.
Methods: This study was conducted from September 1 to November 30,
2013. Two types of device-associated infections in NICU were selected to
be surveyed: central line-associated bloodstream infection (CLABSI) and
ventilator-associated pneumonia (VAP). In this surveillance, the protocol
was based on the National Healthcare Safety Network (NHSN) surveillance
system and used standard infection definitions from the Centers for Disease
Control and Prevention (CDC) for international comparison. We used the
clinical sepsis (CSEP) criterion for CLABSI in addition, to reduce the underes-
timation of CLABSI rate. NICU locations were categorized into two types,
level III or level II/III. The data were collected for each of five birth-weight
categories (<750 g, 751-1000 g, 1001-1500 g, 1501-2500 g, and >2500 g) and
were compared with NHSN data.
Results: A total 16 NICUs ware participated. Pooled mean incidence rates by
birth-weight categories in level III were 9.3, 17.5, 6.7, 0.0, and 11.9 per
1,000 central line-days for CLABSI; 3.3, 0.0, 0.0, 0.0, and 2.7 per 1,000 venti-
lator-days for VAP, respectively. Pooled mean incidence rates by birth-
weight categories in level II/III were 4.4, 1.4, 1.1, 0.0, and 0.0 per 1,000 cen-
tral line-days for CLABSI; 0.0, 1.9, 0.0, 0.0, and 2.2 per 1,000 ventilator-days
for VAP. There were 25 CLABSIs, and 11 (44.0%) of them were identified by
CSEP criteria.
Conclusions: CLABSI and VAP rates in this pilot study were higher than NHSN
data. This finding clearly shows a need for nationwide surveillance system in
Japan.PS 2-516
THE SURVEY FOR SURVEILLANCE OF HEALTHCARE-ASSOCIATED
INFECTION(HAI) IN INTENSIVE CARE UNIT(ICU) AND THE GENERAL WARDS
IN A REGIONAL HOSPITAL FROM 2010 TO 2013
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Purpose: In order to monitor the situation of HAI, we investigate the trend
of the infection sites and the pathogen as the reference of decision-making
in our hospital.
Methods: The beds for both acute and chronic patients are 622. ICU is
divided into Medicine Intensive Care Unit(MICU), Surgical Intensive Care
Unit(SICU), and Respiratory Intensive Care Unit(RICU). We have 11 general
